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Inflammation during development increases risk for neuropsychiatric disorders, including autism. 
Mast cells are a type of innate immune cells present in the brain that modulate inflammation. 
However, their role in brain development is unknown. We have previously shown thousands of 
mast cells reside in the developing rat brain suggesting that they may mediate the effects of early 
life inflammation.  The goals of these experiments were to characterize effects mast cells play on 
the development of social behaviors. To determine if mast cells participate in regular 
programming of social behaviors, we pharmacologically activated or inhibited mast cells during 
the neonatal period and tested social interaction behavior in adulthood. We found that social 
avoidance was decreased in males following mast cell activation.  There were no effects on active 
investigation or passive interaction. Early life activation led to life-long increases in the brain mast 
cell population. We next utilized a prenatal allergic immune challenge to better simulate 
physiologically-relevant mast cell activation during development. We performed a social play test 
on juvenile rats, and found that they engaged in less social play behavior than the control group. 
We are currently testing the effects of allergic challenge on social interaction behavior in adult 
rats. We are also assessed the effects on allergic challenge on the number of mast cells in the in 
brain regions, and found that hippocampal mast cell up-regulation with allergic challenge 
correlates to the observed behavioral decreases in male juvenile play, however females also 
showed a decrease in rough and tumble behaviors that did not correlate with mast cell differences. 
Because neuropsychiatric disorders are more prevalent in males and our lab has previously found 
marked sex differences in the number of mast cells in the developing brain, we determined that 
males and females respond differently to prenatal allergic challenge. Together these studies show 
that mast cells may play a key role in the early life programming of social behavior, and activation 
of these cells following early life inflammation may contribute to the ontogeny of autism. 
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Introduction 
Early life inflammation is a risk factor for neurodevelopmental disorders 
According to the World Health Organization, over 25% of the global population will 
develop some form of mental or neurological disorder in their lifetime (World Health 
Organization, 2001). Neuropsychiatric disorders such as autism spectrum disorders (ASDs) and 
schizophrenia remain serious conditions affecting many families in the United States today. 
Perinatal inflammation and biological sex are two risk factors that contribute to the onset of these 
disorders (Newschaffer et al., 2007). In human mothers, infection, regardless of bacterial or viral 
origin, during the time of pregnancy increase the risk of ASD two fold (Atladottir et al., 2012). 
Furthermore, perinatal inflammation is also common in preterm infants, who also display an 
increased risk for ASDs (Dammann and Leviton, 2000; Johnson et al., 2010). This inflammation 
typically presents itself throughout life both in the periphery and the central nervous system 
(CNS) of ASD patients (Vargas et al., 2005; Ashwood et al., 2011). The higher prevalence of 
allergies and autoimmune disorders seen in autistic individuals also supports immune 
dysfunction as an underlying risk factor (Careaga et al., 2010). Males present ASDs 
approximately four times more often than females, suggesting that males are highly sensitive to 
developmental disturbances (Werling and Geschwind, 2013). Unfortunately, no known cure 
exists and the efficacy of treatments varies greatly depending on the individual (Myers and 
Johnson, 2007). While genetics play a critical role in the development of many neuropsychiatric 
disorders (Colvert et al., 2014), the underlying physiological processes of such disorders remain 
unknown (Werling and Geschwind, 2013). Without knowing the cause of the disease, there is 
little hope of finding a cure.   
  Platko 5 
Rodents subjected to early life inflammation exhibit behavioral similarities to the autistic 
phenotype (Silverman et al., 2010). Several types of cells regulate this immune response in the 
brain. Historically, the astrocytes and microglia were thought of as the main contenders for 
neuronal inflammation, but recent evidence suggests a third type of cell, known as the mast cell, 
plays a critical role in regulating neuroinflammatory processes as well (Silver and Curley 2013).  
However, no research has looked at how mast cells influence neuronal development or how they  
impact later life behavioral changes. For the first time, we look at how perinatal inflammation 
influences mast cell populations in the brain regions associated with social interaction, and how 
these differences may contribute to life-long behaviors in rats.   
Compelling evidence from both clinical and laboratory studies show a strong connection 
in several psychiatric diseases that link the immune system with disorders that also exhibit a 
developmental origin (Schwarz and Bilbo, 2012a). Perinatal immune activation, during a time 
when immune cells are especially plastic, alter long-term function of the immune cells and lead 
to negative changes in memory and learning in males (Schwarz and Bilbo, 2012b). These 
findings reveal that environmental factors impact the immune system and its role in cognitive 
development. While glial cells have been linked to Alzheimer’s disease, Parkinson’s disease, 
schizophrenia and autism, almost nothing is known of the developmental role that mast cells play 
in the ontogeny of these disorders (Silver and Curley, 2013; Patel et al., 2013).  
Function of the CNS immune system during development 
The innate immune system is defined as the nonspecific immune system. In the 
periphery, specialized cells of this system include natural killer cells, neutrophils, monocytes, 
dendritic cells, macrophages and mast cells, which act as the first line of defense against 
invading pathogens. These cells can identify foreign proteins and either engulf and destroy them 
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via a process called phagocytosis or use chemical mediating-signals known as cytokines to 
recruit other immune cells (Grasso, 2012). The CNS also possesses innate immunity, but utilizes 
specialized cells for purposes beyond the typical pathogen recognition.  
In the adult brain, the parenchyma is regarded as an immune privileged site, meaning that 
inflammatory cells typically found in the periphery cannot freely enter or exit to fight infection. 
This reduced immune trafficking combined with the immunosuppressive environment of the 
brain serves as a neuroprotective mechanism (Bechmann and Perry, 2007). Such an environment 
is necessary because excess neuroinflammation can damage the neurons and lead to cognitive 
and motor deficits (Robert, 2007). As a result, a specialized subset of immune cells resides in the 
CNS, which includes microglia, astrocytes, and mast cells. These cells modulate 
neuroinflammation through the release of cytokines, chemokines, and oxidative stress. (Silver 
and Curley, 2013) 
Microglia are the primary innate immune cell of the CNS. These non-neuronal cells are 
derived from common myeloid progenitor cells of the yolk sac which infiltrate the brain around 
gestational day 8 (GD8) in rats (Alliot et al., 1999; Ginhoux et al., 2010) The myeloid 
progenitors then differentiate into microglia (Figure 1), proliferate during the perinatal period, 
and remain a relatively stable population throughout life that is distinct from other peripheral 
macrophages (Alliot et al., 1999; Ginhoux et al., 2010). While historically being associated with 
debris collection and typical pathogen resistance in the brain, microglia also play a unique and 
critical role in brain formation and function (Lenz and McCarthy, 2014).  
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Microglia also play an important role in development through cell proliferation, survival, 
apoptosis, and synaptic pruning (Battista et al., 2006). In vitro studies showed that microglia are 
essential to induce neurogenesis in subventricular neuroprogenitor cells (Walton et al., 2006). 
Furthermore, by pharmacologically suppressing the proinflammatory cytokines (IL-1β, IL-6, 
TNF-α, INF-γ) released by microglia in development, neurogenesis was reduced in the area, 
suggesting that microglia-derived proinflammatory cytokines enhance neurogenesis (Shigemoto-
Mogami et al., 2014). On the other hand, in highly proliferative zones, microglia prevent 
neuronal overpopulation through phagocytosing both apoptotic as well as healthy neural 
precursor cells (Cunningham et al., 2013). Microglia are also drawn to the apoptotic cells of the 
developing brain and release reactive oxygen species to complete the cell death process 
* 
Figure 1: Origin of innate immune cells (Adapted from lecture by 
Godbout, 2014). Mast cells are a myeloid derived granulocyte of the 
innate immune system. They are present in both the periphery and brain 
of rats, mice, humans, and other mammalian species.  
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(Wakselman et al., 2008). Marin-Teva and others showed a similar process in the hippocampus 
and cerebellum, where microglia were attracted to the cell death chemical signal of caspase-3 
(Marin-Teva et al., 2004). This cellular pruning ability also helps develop synapses in the 
hippocampus. Paolicelli detected microglia phagocytosing post-synaptic dendritic spines, which 
relies on the microglia-neuron fractalkine signaling (Paolicelli et al,. 2011). Deficits in synaptic 
pruning, a critical process for development, lead to abnormal or weak neuronal connectivity and 
are implicated in the behavioral changes associated with autism (Zhan et al., 2014; Courchesne et 
al., 2005). Using a rodent fractalkine knockout model (Cx3cr1KO) which prevents microglial 
elimination of immature synaptic connections during development, Zhan and others 
demonstrated that a primary deficit in pruning is sufficient to induce long term behavioral 
characteristics similar to autism, such as impaired social interaction and repetitive behaviors 
(Zhan et al., 2014). Additionally, brain regions typically associated sex specific behaviors, such 
as the POA and hippocampus, have been shown to have a greater population of microglia in 
males than in females, demonstrating one possible mechanism for sexually dimorphic behaviors 
(Courchesne et al., 2005; Lenz, Nugent, et al., 2013; Lenz, Pickett, et al., 2013). However, 
microglia are not the only type of immune cell in the brain. The mast cell is a bone marrow 
derived immune cell that is prevalent in the developing brain and releases neuroactive 
compounds, but its action during development has gone largely uncharacterized (Silver and 
Curley, 2013).  
Mast Cells 
A mast cell is another myeloid derived effector cell of the innate immune system that 
promotes the initial response to injury or infection (Skaper et al., 2012). Historically, mast cells 
have been associated with atopic allergy, asthma, and anaphylaxis. In the periphery, they reside 
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close to epithelia, blood vessels, nerves, smooth muscle cells, in the airways, and in the 
gastrointestinal tract (Metcalfe et al., 1997).  Following injury, they can release proinflammatory 
molecules, or, depending on the environment, act to modulate inflammation (Nelissen et al,. 
2013).  Depending on the location, the phenotype of the mast cells can vary, resulting in differing 
functional properties (i.e. inflammatory, immunological, or physiological) (Bienenstock et al., 
1985; Kitamura, 1989; Galli, 1990). Moreover, mast cells have been observed in the human brain 
and are known to produce histamine and serotonin (Church and Levi-Schaffer, 1997). 
Activation of the mast cells is modulated by cytokines, growth factors, and other 
microenviromental signals (Galli, 1990). One common method of activation and the type 
described in our study utilizes IgE (type E immunoglobulin) and its activation of the FcεRI 
receptor (Stone et al., 2010), causing the release of histamine, serotonin, cytokines, or enzymes 
through a process known as degranulation (Figure 2). In addition to IgE, mast cell number and 
activation can be influenced by hormones like corticotrophin-releasing hormones (CRH) and 
gonadal steroids, neuropeptides and nerve growth factors (NGF) (Crompton et al., 2003; Kulka 
et al., 2008; Lambracht-Hall, 1990). 
 
 
 
 
 
                      
 
Figure 2: Mast cell before releasing regulatory molecules (Left) and after releasing molecules 
(Right). Mast cells are associated with allergy and asthma responses in the brain, releasing 
serotonin, enzymes, and other critical regulatory molecules. (Lenz). 
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Mast cells release many 
neuroactive substances. 
Degranulation causes the 
release of preformed mediators 
located in cytoplasmic 
granules, including vasoactive 
amines, neutral proteases, 
proteoglycans, cytokines, and 
growth factors (Dvorak, 1992; 
Dvorak et al., 1994). Mast cells 
also synthesize 
proinflammatory lipid 
mediators, such as 
prostaglandins and 
leukotrienes, de novo (Gilfillan 
et al., 2011).  Finally, mast 
cells synthesize and secrete 
growth factors, cytokines, and 
chemokines in response to 
various stimuli (Gilfillan et al., 
2011) (Table 1).   
Since they can release biologically active mediators in response to IgE, mast cells are 
typically thought of as the primary effector cells underlying allergic disorders (Gilfillan et al., 
Anti-microbial 
peptides 
Cytokines 
released on 
appropriate 
activation 
Major lipid mediators 
produced on 
appropriate activation 
 
Major mediators 
stored in 
preformed in 
cytoplasmic 
granules 
Histamine, serotonin (in murine 
rodents), heparin and/or chondroitin 
sulfates, neutral proteases (chymases 
and/or tryptases), major basic protein, 
many acid hydrolases, cathepsin, 
carboxypeptidases, peroxidase 
PGE2, PGD2, LTB4 and LTC4, 
platelet-activating factor 
TNFa, TGF-β, MIP-1α, 
VPF/VEGFa, FGF-2a, LIF, IFN-α, 
IFN-β, IFN-γ , GMCSF, MCP-1, IL-
1α, IL-1β, IL-3, IL-4, IL-5, IL-6, IL-
8, IL-10, IL-9, IL-11, IL-12, IL-13, 
IL-15, IL-16, IL-18, IL-25 (and 
probably many more) 
Cathelicidin (human mast cells: LL-
37; murine mast cells: CRAMPb) 
a Evidence indicates that certain cytokines produced by mast 
cells, such as tumor necrosis factor (TNF), fibroblast growth 
factor (FGF)-2 and vascular permeability factor (VPF)/vascular 
endothelial growth factor (VEGF), are released in part from 
preformed stores, some of which may be physically associated 
with the cells’ cytoplasmic granules. 
b CRAMP: cathelin-related antimicrobial peptide. 
Table 1: Summary of many known compounds mast 
cells are capable of releasing upon activation. 
(Adapted by Galli et al., 2005 from Weller et al., 2003)  
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2011). The IgE-induced degranulation can happen within minutes (Galli, 1990). As a result, mast 
cells play a vital role in mediating the immediate effects of anaphylactic and atopic reactions. 
Though evidence for mast cell linkage to chronic conditions like asthma is not completely 
understood (Williams and Galli, 2000), the mast cell stabilization drug, sodium cromolyn, has 
been used for many years to treat asthma (Murphy and Kelly, 1987).  
Aside from their role in the periphery, recent studies have begun to focus on their role in 
the brain. Just as the microglia progenitor cells migrate to the brain, mast cells take up residence 
in the developing brain as well (Lambrecht-Hall et al., 1990). Mast cells can also pass through 
the blood-brain barrier (BBB) under normal conditions and lie on the brain side near the blood 
vessels (Silverman et al., 2000). They sense the local environment and will release different 
neuroactive compounds (Galli et al., 2005), including histamine, prostaglandins, growth factors, 
TNF-α, IL-6, IL-13, and serotonin even during baseline conditions (Skaper et al.,2012; Kim et 
al., 2010, Walker et al., 2012). In the developing rat brain, the cells primarily populate the velum 
interpositum, the area directly underneath the hippocampus, and peak in number at postnatal day 
4 (PN4) (Tuomisto and Panula, 1991).  
While brain-resident mast cell counts are relatively small compared to the numbers of 
brain-resident microglia and astrocytes, they release a large amount of preformed granular 
material (picograms per cell) or continue synthesizing mediators for several hours following 
activation, allowing for prolonged effects on the glial and neuronal cells (Silver and Curley, 
2013). For example, activated mast cells can produce proinflammatory chemokines, which 
induce an activated profile in microglia (Marshall, 2004). The microglia then release factors like 
Interleukin 6 (IL-6) and CCL5 which could alter the receptor expression on the mast cells 
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(Pietrzak et al., 2011). There is likely a high degree of crosstalk between mast cells and other 
immunocompetent cells in the brain that have yet to be characterized.  
 Alterations of mast cell number and activation state can lead to behavioral changes. In 
mast cell deficient genetic model mice, neurogenesis and hippocampal dependent behaviors in 
adults were negatively affected, but treatment with a serotonin selective reuptake inhibitor 
reversed the effects (Nautiyal et al., 2012).  The findings support the idea that mast cells 
contribute to proper function of the hippocampus through serotonergic release even in the 
absence of inflammation. However, behavioral changes linked to differences in mast cell number 
and activation likely results from a change in the balance of the many mediators present in the 
brain so a simple linear relation between number, degranulation, and behavioral differences is 
improbable (Silver and Curley, 2013). No studies have looked at the impact of acute mast cell 
manipulations during development, or assessed whether behavioral changes seen in congenitally 
mast cell deficient mice are due to the developmental or adult actions of brain-resident mast 
cells.  
Serotonin, histamine, and other mast cell mediators are implicated in brain 
development and function 
 Many of the compounds mast cells produce have been shown to be essential for proper 
brain development. Serotonin (5-HT), for instance, is one of the most widely studied 
neurotransmitters and an influential tropic factor during development of the mammalian brain. In 
a study using genetic knockout mice, serotonin was determined to be a necessary factor for 
properly shaping embryonic neuronal structures (Cote et al., 2007). However, excess embryonic 
serotonin also leads to abnormal cortical development and neuronal migration. In the postnatal 
brain, disruptions of synaptic connectivity result from altered serotonin levels prior to puberty 
(Ricco et al., 2009; Chugani et al., 1999). Experiments in rat pups determined that 
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pharmacological depletion of serotonin lead to a lengthened period of cell division in brain 
regions with dense serotonergic innervations, resulting in an increase of neuronal cell numbers in 
the hippocampus, superior colliculus, and several thalamic nuclei (Lauder and Krebs, 1978). 
Recent findings in a rodent model concluded that serotonin requires a homeostatic balance 
during development to provide a necessary signal for serotonergic neuronal wiring, and 
abnormalities in this balance negatively affect this neuronal circuitry in areas like the 
hippocampus and thalamic nuclei (Migliarini et al., 2013). These results reflect observations in 
human children. All children typically have elevated serotonin levels until 15 years of age, but 
autistic patients often experience difficulties in their capacity to synthesize this neurotransmitter 
(Chugani et al., 1999). Improper development of areas shaped by serotonin leads to adverse 
behavioral characteristics resembling autism (Whitaker-Azmitia et al., 2005). When treated with 
a serotonin transport blocker to increase levels, rats exposed in early life experienced a change in 
exploratory and stress response behaviors while adults that underwent the same treatment did not 
experience any change, implying that the effects are exerted during a developing stage of life 
(Ansorge et al., 2008).  
 Histamine (HA) in the adult brain regulates behaviors including the sleep-wake cycle, 
feeding, and neuroendocrine function. In development, histamine levels typically are elevated 
compared to the adult brain, suggesting a role in proper brain formation as well (Pearce and 
Schanberg, 1969). Most histamine in the developing brain has been attributed to mast cells 
(Tuomisto and Panula, 1991) and genetically blocking mast cell development reduces brain 
histamine levels (Nautiyal and others, 2008). The mast cells that contain histamine are first 
observed on gestational day 18-19 and mainly reside directly underneath the developing 
hippocampus (Tuomisto and Panula, 1991). Cell numbers increase until PN 4, after which their 
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number declines towards the adult level (Tuomisto and Panula, 1991). Histamine deficits have 
been implicated in the developmental disorder Tourette’s syndrome, and recent findings showed 
that a genetic knockout developed to block histamine synthesis through altered enzyme function 
lead to a phenotype of the disease in a mouse model including frequent repetitive motions, also a 
characteristic of autistic behavior (Castellan et al., 2014). The same study also found that humans 
with the correlating genetic polymorphism were at a high risk for developing the disorder.  
In vitro studies looking at the neural stem cells observed that histamine acts to induce 
proliferation and neuronal differentiation of neural stem cells (Molina-Hernandez, 2008). While 
neural stem cells are known to express histaminergic receptors, receptor knockout mice do not 
exhibit developmental abnormalities from lack of histamine (Molina-Hernandez, 2008). Overall, 
however, the role of histamine in the developing CNS is not yet well characterized (Panula and 
Nuutinen, 2013).  
Sex differences in brain-resident innate immune cells 
Mast cells have been shown to play a significant role in development, central nervous 
system immunological inflammatory responses, and everyday physiological functioning through 
the release of neuromodulatory chemicals (Silver and Curley, 2013). After fertilization, 
hormones direct mast cell activity through differentiation in the developing fetus that leads to the 
development of characteristics common to each gender. Previous and ongoing work from our 
laboratory shows that if mast cell activation is increased during this early organization phase of 
brain sexual differentiation, male-typical copulatory behavior will be observed in female rats, 
months later in adulthood (Lenz and McCarthy, 2014). Males also exhibit a much greater number 
of both microglia and mast cells than the females (Figure 3), with the males showing lifelong 
differences in microglia (Lenz, Nugent, et al., 2013).  
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With these changes in mind, it is 
interesting to note that many 
neuropsychiatric disorders, in particular 
those with developmental origin, present 
themselves much more frequently in 
males. Autism, schizophrenia, ADHD, and 
Tourette’s syndrome all develop more 
frequently in males and seem to have some 
inflammatory component underlying their 
onset. Males typically present 
developmental abnormalities early in life in conditions like autism or schizophrenia, while 
females tend to present symptoms later in life like depression and anxiety disorders (Schwarz 
and Bilbo, 2012). We hypothesize this difference may play a role in the sex bias of ASDs.  
Disrupted social behavior is a hallmark phenotype for neuropsychiatric disorders 
While inflammation in the brain has been shown as a risk factor for developing 
neuropsychiatric disorders in humans, behavioral changes remain the current reliable diagnostic 
criteria (Silverman et al., 2010). According to the DSM V, three main diagnostic criteria of 
autism include deficits in social interaction and communication, restricted or repetitive behaviors 
(Silverman et al., 2010; American Psychiatric Association, 2013) and exhibit symptoms during 
early development. Abnormal social interaction consists of behaviors like reduced interest in 
peers, difficulty maintaining social interactions, and failure to use appropriate eye contact or 
facial expressions. Impaired communication relates to difficulties in verbal communication 
ranging from comprehension of words or understanding of verbal context to exaggerated or 
Male Female 
Total Hippocampal Mast Cells (PN2) 
*
*
Figure 3: Significant sex differences in the 
number of hippocampal mast cells on PN2 
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monotonous speech. Repetitive or restricted behaviors include rituals, compulsions, routine 
preservation, and narrowed interests (Silverman et al., 2010). However, no single biological 
marker has been identified (Voineagu et al., 2011); hence, behavioral assessment remains the 
widespread diagnostic tool (Johnson and Myers, 2011). In our study, we use the rat, a highly 
social species, as a model to assess the behavioral changes that result following pharmacological 
or allergic activation of mast cells, with a focus on the social behavior aspect of ASDs. 
 Our study chose to focus on the social behavior changes in rats that correlate to the 
diagnostic criteria. To do so, we utilized a rodent model and looked at the standard parameters 
used to assess behavior (Silverman et al., 2010). Behavioral assays primarily focus on reciprocal 
social interaction. We did not assess their inclination for repetitive behaviors or impaired 
communication. Our lab is assessing behaviors that have been shown to be impaired in the 
currently accepted transgenic rodent models of autism (Silverman et al., 2010; Zhan et al., 2014). 
LPS-induced perinatal inflammation altered the behavior in a similar manner (Taylor et al., 
2012). Our model aims to illustrate the autistic behavioral phenotype by examining the 
environmental factors thought to play a risk factor in modulating social behavior.    
Social play shows a robust sex difference 
Social play is the type of social behavior that develops in juvenile rats around PN18 and 
continues throughout puberty (Meaney, 1981). These behaviors are thought to prepare the rats 
for adaptive behaviors in adulthood (Auger and Olesen, 2009).  In both humans and rodents, 
males are predisposed to more frequent rough and tumble play behaviors (Auger and Olesen, 
2009; Jarvis, 2007). During development, different hormone levels in males and females lead to 
differing number of glial cells in the amygdala which lead to masculinized play behaviors in 
female rats, though male behavior was unaffected (Krebs-Kraft et al., 2010). Lesions to the 
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neonatal amygdala drastically decreased male play behavior, reducing them to the same level as 
the female control animals (Meaney et al., 1981). 
Several other areas of the brain are thought to be associated with modulating social 
behavior, including the bed nucleus of the stria terminalis (BNST; a part of the extended 
amygdala), the ventral hippocampus, habenula, and septum. Since the BNST shares strong 
connections with the amygdala, lesions here would likely alter behavior, though little work has 
been done to show this (Auger and Olesen, 2009). Male rats treated with LPS prenatally had 
observable differences in vasopressin expression in the amygdala as well as reduced social play 
behaviors while females did not show the same differences, demonstrating both the role of the 
BNST in behavior and the male vulnerability to inflammation (Taylor et al. 2012). Using 
optogenetics, one study demonstrated that inhibiting projections from the basolateral amygdala 
to the central amygdala induced anxiety behavior in rats with the open field and elevated plus 
maze tests (Tye et al., 2011).  Alternatively, lesions to the neonatal septum areas increased the 
social play across both genders though males retained higher play bouts (Beatty et al., 1982). The 
amygdala also projects to the ventral hippocampus. Previous work has shown excitatory inputs 
from the basolateral amygdala to the ventral hippocampus down-regulate social behavior (Feliz-
Ortiz, 2014). Furthermore, the ventral hippocampus plays a role in anxiety behaviors. 
Specifically, lesions to the ventral hippocampus, and not the dorsal hippocampus or amygdala, 
reduce anxiety behavior (McHugh, 2004). This suggests involvement of a pathway affiliated 
with the decreased social interaction seen in ASD patients. Recent findings suggest that deficits 
in the CA2 region of the hippocampus impair social learning (DeVito et al., 2009). Many mast 
cells reside under the CA2 area of the hippocampus during development, which implies a 
possible interaction.  
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Van Kerkhof demonstrated that the habenula processes a reward signal affiliated with 
social play, particularly in young rats (Van Kerkhof, 2013). Pharmacological lesions in the 
habenula produced social isolation, suggesting this region’s possible role in the social 
impairments of autistic behaviors (Van Kerkhof, 2013).  
These series of experiments aimed to characterize a 
role mast cells play during development and their 
influence on shaping the brain to program 
the development of social behavior. 
Previously, our lab looked at juvenile 
social play behavior after treating pups 
with compound 48/80, the same mast cell 
activating drug used in this study. We 
found a 40% reduction in male social play 
(Lenz and Galen, unpublished; Figure 4).  
We wanted to expand upon this work utilizing 
pharmacological manipulations to directly observe mast 
cell influences on later life behavior. The following test 
used a more biologically relevant prenatal immune 
activation before observing behaviors (Figure 5). For the first time we show that direct mast cell 
activation leads to different adult social interaction, and that prenatal inflammation leads to mast 
cell changes, which correspond to behavioral changes. Our results are consistent with 
epidemiology showing that early life inflammation increases risk for impaired social behavior, as 
seen in autism and other neuropsychiatric disorders.  
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Figure 4: Juvenile play 
behaviors observed in male 
rats following PN1 C48/80 
treatment 
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  Figure 5: General schematic of experiment. We observe mast cells in the developing brain 
which peak in number around PN4. Activated mast cells release their content through 
degranulation. We hypothesize that alterations in the number of these cells will influence 
later life behaviors through developmental changes. 
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Methods 
In vivo manipulations 
All breeding and experimental procedures were approved by The Ohio State University 
IACUC committee. Adult Sprague Dawley (Harlan) were mated in our facility, or timed 
pregnant animals were ordered to deliver approximately one week prior to parturition. Animals 
were maintained on a reverse 12:12h reverse light/dark cycle with lights off at 0800 hr, with ad 
libitum food and water in our vivarium. Pregnant rats delivered all pups naturally.  
Pharmacological manipulations using Cromolyn and 48/80 injections 
Bilateral intracerebroventricular (i.c.v.) injections were performed under cryoanesthesia on 
the day of birth (PN0) and on PN1 (N = 49). A 23 gauge 1 μl Hamilton syringe attached to a 
stereotaxic manipulator was placed 1 mm caudal to Bregma and 1 mm lateral to the midline, 
lowered 3.0 mm into the brain, and then backed out 1 mm. A total of 1μl of drug or vehicle was 
infused over approximately 30 s, and the procedure repeated on the other hemisphere. For all 
procedures, the separation of pups from the dam was kept to a minimum, with i.c.v.-injected 
animals being separated for ∼30 min. Each treatment group received two treatments of a mast 
cell stabilizer known as cromolyn sodium salt (cromolyn) (SigmaAldrich) to prevent mast cell 
degranulation (10 µg/µl; 20 µg total dose; n = 8 male, n = 7 female), a mast cell secretagogue 
known as compound 48/80 (SigmaAldrich) to induce degranulation (0.5 µg/µl; 1 µg dose; n = 10 
male, n = 7 female), or vehicle (1 µl saline), n = 9 male, n= 8 female). Our previous studies 
showed the specified timing and dosing to be effective in mast cell regulation in the neonatal 
brain (Lenz and Galan, 2014). After neonatal treatment, animals used for behavioral testing were 
weaned at PN22 into sex-specific groups of two to three.  
  Platko 21 
 
Social Interaction 
 Social interaction test measures social exploration behaviors toward an unfamiliar 
conspecific animal. Adult social interaction paired a test animal (PN70, N=49, Figure 6) with an 
unfamiliar same-sex conspecific in a single 10 minute test. Four litters consisting of male vehicle 
(saline; n=9), cromolyn (mast cell stabilizer; n=8), and compound 48/80 (mast cell activator; 
n=10), female vehicle (n=8), cromolyn (n=7), and compound 48/80 (n=7) were used in the 
behavioral assessment. Social behavior in rats often depends on reciprocal behaviors of the other 
animals present, so a stimulus untreated conspecific was paired with the test animal. The animals 
were undisturbed and videotaped in a red-lit 48 × 38 × 30 cm (l × w × h) Plexiglas box during 
the dark phase between 0900 and 1500 hr. Behaviors recorded in the videos were scored blind to 
the treatment of the animal.  Scored behaviors include: avoidance behaviors (when the test 
animal was approached by the stimulus animal and the test animal moved away), number of 
investigative behaviors (when test animal sniffed, initiated contact, or actively investigated the 
stimulus animal), amount of time investigating stimulus animal, and amount of time passively 
interacting with the stimulus animal (test animal was in direct physical contact with the stimulus 
animal but was directing no active investigation towards the stimulus animal).  
 Figure 6: Timeline of neonatal pharmacological manipulations 
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Pharmacological manipulations with Ovalbumin 
Prior to pregnancy, adult females were sensitized with 1 mg ovalbumin injection (OVA 
grade V, SigmaAldrich) prepared at 4 mg/mL in pyrogen-free 0.9% saline and precipitated at a 
1:1 ratio with Al(OH)3 (Imject Alum, Thermo Scientific) according to manufacturer’s 
instructions. After two weeks, a second 1 mg ovalbumin injection was given. A week later, 
females were paired with male for breeding. Detection of sperm signaled gestational day 0 
(GD0). At GD15, pregnant rats were challenged intranasally with 1% ovalbumin (0.01g/ml) or 
saline solution (50µl), which was placed on each nare under light isoflurane anesthesia and 
inhaled upon regaining consciousness. 
The females were observed for one hour 
following the challenge and showed no 
signs of sickness behavior, anaphylaxis, 
or other distress. We have previously 
demonstrated that this allergic challenge 
procedure produces a significant increase 
in serum IgE in the females 1 hr after the 
challenge (Lenz and Galan, 2014, Figure 
7).  Females were paired with one other 
female rat until GD15 then were housed individually. After birth, animals used for behavioral 
testing were weaned at PN22 into sex-specific groups of three.  
 
 
Figure 7: Serum levels in mother one hour after 
ovalbumin injection 
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Social Play 
Rough and tumble play behavior is a typical paradigm used in assessing juvenile social 
interaction (Auger and Olesen, 2009). Between PN28-38, ovalbumin-treated and related control 
animals were placed in mixed sex and treatment groups of six or seven animals, containing at 
least three males. Two ovalbumin treated litters (males n=10; females n=11) and one vehicle 
litter (males n=6; females n=5) were used. Rats were undisturbed and videotaped in the arena for 
13 minutes to allow for a 3 minute habituation period and 10 minutes for behavioral scoring.  
Testing occurred daily for 5 days beginning ~1000-1300 hours during the dark phase (Figure 8). 
To differentiate between animals in the recording, each subject was given a unique identifying 
symbol marked on their dorsal side with Sharpie marker. After marking, the rats were 
undisturbed for at least 40 minutes prior to testing.  The entire group was placed in a bedded 48 × 
38 × 30 cm (l × w × h) Plexiglas arena under red light. After testing, rats were returned to their 
sex-specific home cages. Five behaviors - pouncing, chasing, wrestling, boxing, and pinning - 
were considered when scoring. Auger et al. defines the typical play behaviors we observed: 
“pouncing, the act of jumping on or placing both forepaws on the dorsal surface of another 
animal. A chase was counted whenever a rat made a sustained pursuit of another rat. Boxing 
Figure 8: Timeline of allergic challenge 
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occurs when both rats stand on their hind paws and shove each other with their forepaws. 
Wrestling occurs when two rats roll and tumble over each other. Pinning, or one rat holding 
another in a supine position, is often the result of boxing and wrestling bouts” (Auger and 
Olesen, 2009). Behavioral testing was videotaped and frequencies of play behaviors of each 
animal were quantified with experimenter blind to condition. 
Tissue Collection and Analysis  
 Brain tissue of pharmacological and ovalbumin treated adult and perinatal (PN4) rats 
was collected for histological analysis. For histology experiments, animals were injected 
intraperitoneally (i.p.) with FatalPlus (Vortech Pharmaceuticals), transcardially perfused with 
0.1 M PBS followed by 4% paraformaldehyde, their brains removed and postfixed overnight in 
4% paraformaldehyde, and cryoprotected with 30% sucrose until they sank. All brains were 
coronally sectioned on a cryostat into three alternate series at a thickness of 45 μm. Sections 
were mounted on Superfrost Plus slides (FisherBrand). One series underwent histological 
staining for mast cells using toluidine blue (FisherChemicals). The stain highlights the 
metachromatic properties of the mast cell granules while lightly counterstaining the remaining 
neural tissue (Gokul and Shankar, 2012). Sections were washed in 60% EtOH for 2 min before 
they were stained in acidified 0.5% toluidine blue (pH=2.0). Excess stain was removed with a 
brief rinse in distilled water. Sections were then dehydrated with ascending alcohol (50% EtOH 
for 15 sec, 70% EtOH for 45 sec, 95% EtOH for 2 min, and 100% EtOH for 2 min.), defatted 
with xylenes (5 min, ×2), and coverslipped with Permount mounting medium (Fisher 
Chemicals).  
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Mast cell imaging and counts 
All sections were imaged using light microscopy with a 40× objective. Total mast cell 
counts were performed across the BNST, lateral septum, medial septum, amygdala, 
hippocampus, and habenula using computer based stereology software (StereoInvestigator, 
Microbrightfield) interfaced with a Zeiss AXIO Imager.M2 microscope and a Zeiss AxioCam 
MRm Digital Camera. All visible mast cells in the region of interest were counted manually. 
Distinctions between granulated and degranulated mast cells were also made. Granulated cells 
were characterized as darkly stained, concentrated granules, and a more circular shape.  
Degranulated cells showed lighter staining, more dispersed granules, and less defined structure 
(Figure 2). 
Statistical Analysis 
For all datasets, individual numbers of social behaviors and numbers of mast cells were 
tabulated. Data were analyzed using two-way ANOVA tests and graphs were prepared using 
GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Where significant effects were 
discovered using ANOVA, the Turkey’s post-hoc comparison test was utilized to determine 
which groups were significantly different from one another.  Alpha value was set at 0.05. All 
mast cells were totaled and normalized by multiplying the average number of cells per section by 
the animal with the largest number of sections to account for slight variations in number of 
sections per animal. The pharmacology experiments compared three factors when calculating 
statistics: vehicle, cromolyn, and compound 48/80 treatments. OVA experiments compared two 
factors, ovalbumin-treated and untreated animals.  
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Results  
Adult mast cell numbers following early life pharmacological treatment 
 
Two-way ANOVA revealed a significant sex difference (F1,8=29.71, p=0.0006), significant 
overall effect between early life and adult mast cell numbers (F1,8=1234, p<0.0001), and a 
significant interaction effect (F1,8=27.27, p=0.0009). Turkey’s post hoc analysis revealed 
significantly more mast cells in PN4 
males  as compared to PN4 females 
(p=0.0003), PN4 compared to PN80 
males (p<0.0001), PN4 males 
compared to PN80 females 
(p<0.0001), PN4 females compared to 
PN80 males (p<0.0001), and PN4 
females compared to PN80 females 
(p<0.0001). Mast cell counts of the adult 
brain were shown to much lower in 
adults than in the pups of all treatment 
groups (p<0.0001, Figure 9). No significance was seen between PN80 males and PN 80 females.  
Social interaction following early life mast cell manipulations 
 For social avoidance behavior, two way ANOVA revealed a significant main effect in 
pharmacological treatment in males(F2,41=3.391, p=0.0434) but no sex difference (F2,41=1.606, 
p=0.2122). There was also a significant interaction effect (F2,41=3.965, p=0.0269). Post hoc 
analysis determined that social avoidance behaviors decreased in males after early life treatment 
with compound 48/80 compared (mast cell activator) to the control group (p=0.0422; Figure 
Figure 9: Number of mast cells observed in vehicle 
PN4 rats compared to number observed in vehicle 
adult brain. 
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10A). No other treatment comparisons showed any significant differences (Figures 10B-D). 
Upon visual analysis of these data, we excluded the cromolyn (mast cell stabilizer) treatment 
group which showed no significant difference from vehicles, to increase power. After doing so 
and re-performing two-way ANOVA, ANOVA revealed significant treatment difference 
(F1,28=9.459, p=0.0047), sex difference (F1,28=11.18, p=0.0024), and interaction effect 
(F1,28=27.20, p<0.0001). Post hoc analysis once again determined that social avoidance behaviors 
decreased in males after early life treatment with compound 48/80 (p<0.0001). Female vehicles 
showed significantly less avoidance behaviors compared to the male vehicles (p<0.0001). 
Females treated with C48/80 showed fewer avoidance behavior than vehicle males (p=0.0007).  
No other social interaction behaviors showed a significant difference. This includes number of 
active investigations, time actively investigating the stimulus animal, or time spent passively 
interacting with the stimulus animal. 
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Figure 10 : ci l Avoidance Figure 10B: Active Investigation (bouts) 
Figure 10C: Active Investigation (s) Figure 10D: Passive Interaction (s) 
Figure 10: Social behaviors observed in the adult rats. All behavior was scored in one 
session paired with a same sex untreated conspecific. 10A: Social avoidance was the only 
adult behavior to show significant differences. This behavior includes any effort made by the 
test subject to keep away from the stimulus conspecific. While the differences showed the 
expected sex difference, an increase, rather than decrease, in avoidance behavior was 
expected 10B: Active investigation bouts include number of times the test rat approached the 
conspecific. 10C: Time the subject performed investigative behaviors like sniffing or 
placing forepaws on conspecific. 10D: Time the test rat was touching the stimulus animal 
but exhibited no investigative behaviors.  
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To assess any long term cellular changes, animals were sacrificed after the behavioral 
trials and the brain regions were compared. Mast cells were almost exclusively localized to the 
thalamus in adults and were quantified. Treatment with mast cell modulating drugs during the 
early perinatal period did not alter the number of mast cells in the adult thalamus (F2,10=3.496, 
p=0.0706; Figure 11). 
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Figure 1  alamus Mast Cells 
Figure 11: Number of mast cells in the adult thalamus. This was the 
only area that exhibited mast cells in the adult.  
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Mast cell counts following prenatal allergic challenge  
 Prenatal allergic challenge significantly altered mast cell number in the postnatal 
hippocampal region (n= 3 per group). ANOVA revealed a significant total mast cell sex 
difference was also seen (F1,8=29.32, p=0.0006), but no significant ovevrall treatment difference 
was observed (F1,8=0.4721, ns). A main interaction effect in number of total mast cells in the 
hippocampus was significant (F1,8=18.05, p=0.0028). Post hoc analysis revealed significant 
differences in total hippocampal mast cells between: male vehicle (MV) and male OVA 
(MOVA) (p=0.0334); MV and female OVA (FOVA) (p=0.0410);  MOVA and female vehicle 
(FV) (p=0.0110); and MOVA and FOVA (p=0.0006; Figure 12). No total mast cell differences 
were seen between other comparisons.  
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Figure 12: Total Mast Cells in ippoca pus 
Figure 12: Total number of mast cells in the PN4 rat following 
gestational allergic challenge 
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The number of granulated mast cells in the hippocampus also showed overall granulated 
mast cell sex difference (F1,8=28.41, p=0.0007), but no treatment difference was seen. 
(F1,8=0.4267, ns). There was a significant interaction (F1,8=19.68, p=0.0022). Post hoc analysis 
revealed significant differences in granulated hippocampal mast cells between MV and MOVA 
(p=0.0412); MOVA and FV (p=0.0171); and MOVA and FOVA (p=0.0006; Figure 13). No 
total mast cell differences were seen between other comparisons.   
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Figure 13: Granulated ast ells in Hippocampus 
Figure 13: Number of granulated mast cells in the PN4 rat following 
gestational allergic challenge 
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In number of degranulated hippocampal mast cells, there was an overall sex difference 
(F1,8=5.711, p=0.0439), but no overall significance between treatment groups (F1,8=0.6677 ns). 
No significant interaction effect was seen in degranulated hippocampal mast cells (F1,8=0.0967, 
ns; Figure 14). Post hoc analysis revealed no other significant comparisons.  
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Figure 14: Degranulated Mast ells i  i oca pus 
  Males   Females 
                  * 
Figure 14: Number of degranulated mast cells in the PN4 rat 
following gestational allergic challenge 
  Platko 33 
Other areas in the brain thought to be involved with behavior also showed no significant 
differences in total number of mast cells by sex, treatment, or interaction: amygdala (F1,8=1.114, 
ns, Figure 15), BNST (F1,8=0.6040, ns ), habenula (F1,8=3.080, ns), and lateral and medial 
septum (F1,8=2.208, ns). These other areas showed no significant sex differences in total number 
of mast cells: amygdala (F1,8=0.1303, ns), BNST (F1,8=0.1236, ns ), habenula (F1,8=0.0287, ns), 
and lateral and medial septum (F1,8=0.0338, ns). They also showed no significant treatment 
differences in total number of mast cells: amygdala (F1,8=0.0230, ns), BNST (F1,8=0.8146, ns), 
habenula (F1,8=0.0011, ns), and lateral and medial septum (F1,8=1.641, ns). 
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Figure 15: Total ast Cells in Other Regions 
Figure 15: Number of total mast cells observed in the PN4 rat following 
gestational allergic challenge in other areas previously shown to play a 
role in social behavior. Bed nucleus of stri terminalis (BNST); amygdala 
(amy); habenula (hab); lateral septum (septum) 
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Prenatal allergic challenge behavior 
In total, the behavior of OVA males (MOVA) and eleven OVA females (FOVA) derived 
from two litters was compared to the behaviors of six male vehicle (MV) and five female (FV) 
vehicle pups from one litter. The data were averaged across groups and normalized for minor 
differences in the number of trials. ANOVA showed that prenatal treatment with ovalbumin had 
no significant overall sex differences (F1,28=1.382, ns), but revealed significant treatment effects 
(F1,28=21.87, p<0.0001). No interaction (F1,28=2.407, ns) were seen. Post hoc analysis revealed 
significance in MV and female OVA (FOVA) (p=0.0010) and between FV and FOVA 
(p=0.0010). No other comparisons were significant.  
To determine if specific play behaviors were affected by the allergic challenge, we 
looked at chasing behavior separately from the other rough and tumble behaviors (boxing, 
pinning, pouncing, and wrestling). ANOVA revealed no significance between sex (F1,28=2.286, 
ns) but did show an overall effect between treatment groups in chase behavior (F1,28=12.89, 
p=0.0012). There was no overall interaction effect (F1,28=0.5577, ns). Post hoc analysis showed 
significance decreases in MOVA compared to MV (p=0.0197) and in FOVA compared to MV 
(p=0.0043) in chasing behavior. No differences were seen between other comparisons. ANOVA 
revealed no overall sex difference between groups in rough and tumble play behaviors 
(F1,28=0.5586, ns), but did show an overall treatment difference (F1,28=4.458, p=0.0438). There 
was also an interaction effect (F1,28=7.675, p=0.0098).  Post hoc analysis showed significance 
decreases in female vehicle versus female OVA (p=0.0101) and in male OVA versus female 
OVA (p=0.0268), while no differences were observed between other comparisons.  (Figure 16A 
and B).  
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Figure 16A: Juvenile Social hase Behaviors 
Figure 16B: Juvenile Social Play: Rough a  l   
Figure 16: Number of chase behaviors (A) and rough and tumble play 
behaviors (B) observed in the juvenile rats (PN28-35) following 
allergic challenge 
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Discussion  
In this study, we focused on an area not previously explored: how changes in mast cells 
during development influence later life behaviors in the juvenile or adult rat. In the first 
pharmacological manipulations, we found that activation of mast cells decreased social 
avoidance in adult males while females went unaffected. These data correspond to the previous 
study in our lab where social play behavior of juvenile males, but not in females, was decreased. 
However, these results were partially unexpected because the autistic phenotype would be 
expected to avoid social contact. We followed this study by looking how prenatal inflammation 
would affect the same behaviors. In the juvenile rats, we saw our expected results that ovalbumin 
challenged rats displayed a decrease in social behaviors, and males saw a decrease in social 
chase behaviors. These differences corresponded, as expected, to an increase of mast cells. 
However, it was unexpected to see a decrease in rough and tumble play in the females while no 
difference was seen in the males.  
Pharmacological treatment 
 Our first experiment to test the involvement of mast cells in programming later life 
behavior showed a significant decrease in social avoidance in male rats when mast cells were 
activated by C48/80 at PN0-1. Additionally, male and female vehicles displayed a sex difference. 
Previous work in our lab, using the same paradigms used to assess juvenile behavior in allergic 
challenge animals, found that males showed social play was reduced by 40%, but no differences 
in females were observed when treated with the same mast cell degranulating agent (Lenz and 
Galan, unpublished). The sex difference in behavioral change carried over in this study’s 
observation that rats with early life mast cell activation exhibited significantly less social 
interaction as adult males. These results show that by directly stimulating these cells at an early 
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developmental time point mast cells play some role in the developing brain that can preprogram 
lifelong behavioral changes.  
 Several studies have demonstrated that males are more vulnerable to changes during 
development that contribute to neuropsychiatric disorders (Bale, 2011; Taylor et al., 2012). One 
explanation suggests the existence of currently unknown modulating factors present during 
gestation that either serve as a protective factors in females or a detrimental factors in males or 
some combination of the two (Marshall, 2004; Pietrzak et al., 2011). With mast cells capable of 
producing such a wide variety of regulatory compounds, their products might contribute to such 
changes.  Since male behaviors were affected more than females’ with drug-induced mast cell 
activation, this points to the conclusion that mast cell activation plays a role in development of 
areas associated with social behavior. The fact that males also have significantly more mast cells 
without any treatments and that dysregulation of this cell type induces sex biased behavioral 
changes supports the hypothesis that mast cells might be an underlying factor for the sex bias 
observed in neuropsychiatric disorders. We do not yet know whether the sex difference is 
programmed directly by male-typical hormones during development, by sex chromosomes, or 
whether mast cells are recruited differentially into the brain via other local cells, such as 
microglia, neurons, astrocytes, or endothelial cells of the blood brain barrier.   
 However mast cell stabilizer cromolyn showed no significant effect in either sex. One 
explanation might be the effectiveness of cromolyn, the dose used, or the dosing schedule. 
Cromolyn has been shown to have varying degrees of effectiveness in blocking degranulation in 
peripheral mast cells (Barrett and Metcalfe, 1985), so completely blocking the mast cells might 
not have been achieved allowing for any necessary developmental effects to be compensated by 
other mast cells. Also administering the drug i.c.v. could have induced local inflammation and 
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non-specific activation of mast cells or other immune cells to counteract the effectiveness of 
pharmacological mast cell inhibition. Future studies could address this by giving cromolyn 
systemically or increasing the dose given. 
 Furthermore, the adult reduction of social avoidance after mast cell activation is not 
necessarily indicative of autistic-like behavior, since behavior typically includes aversion to 
touch in humans (American Psychiatric Association, 2013; Silverman, 2010). This could indicate 
that the mechanism underlying this social behavior might be more influential at an earlier time 
point during development. On the other hand, since the disease falls on a spectrum, few if any 
individuals and no current model exhibit every characteristic of autism (American Psychiatric 
Association; Silverman, 2010). 
 Aside from social interaction, no other behaviors were affected. Confounds of both drugs 
might be possible due to timing of administration. Since the drugs would have been exerting 
their effects on PN0-1, brain development would more complete than when rats are challenged 
prenatally at GD15, meaning if mast cells had effects on hippocampal development, they would 
be less effective following drug administration since any neural networks would be much more 
strongly formed. Moreover, each drug does not necessarily resemble any naturally occurring 
environment. Even though compound 48/80 and cromolyn have been shown to act on the mast 
cell’s FcεRI, the same receptor activated by IgE (Shapiro and P König,1985), true inflammation 
would likely have impacted the surrounding microglia and elicited other inflammatory factors to 
be spread throughout the developing parenchyma. Since the compounds synthesized by the mast 
cells are often determined by the environment (Galli et al., 2005), stimulating degranulation 
without other inflammatory markers does not model the mast cell role in development.  Future 
experiments will address this by co-administering a systemic immune challenge with LPS and 
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concurrently inhibiting mast cells with cromolyn to tease out the specific effects of mast cells on 
the development of social behavior. 
Allergic challenge  
 The allergic challenge sought to expand on the results of our pharmacology experiment 
by replicating a more biologically relevant factor. Inflammation that has been shown as a risk 
factor for autism is usually marked by an elevation in a wide range of cytokines and other 
modulating factors. By sensitizing and challenging the mother during gestation with ovalbumin, 
we mimicked the typical allergy- related immune response that might be seen during pregnancy 
in humans.   
 Prenatal allergic challenge led to decreased social behavior in males and females. When 
challenged with OVA during gestation, male juveniles chased significantly less while their rough 
and tumble behavior did not change. The decline in social chase behavior in juvenile males 
correlated to the increase of mast cells in the hippocampus. Both total and granulated mast cells 
showed a significant increase in the males while remained more stable in the females. Although 
the number of degranulated mast cells did not produce statistically significant results, adding 
more subjects to the data would likely show significant differences. With both the 
pharmacological degranulator and allergic challenge, male behavior significantly changed, 
suggesting a link between increased number of mast cells mast, and therefore their mediators, 
and later life social behavior. The females displayed a seemingly opposite trend, since OVA 
female chase behaviors did not show significance while their rough and tumble behavior did 
show significant decline. These results were unexpected. Further studies will look to add subjects 
in both the social play and mast cell counts.  
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 Decreases in juvenile male chasing behavior is reminiscent of the decline in social 
interaction in autism. However, no decrease was seen in rough and tumble behaviors. Females 
displayed a decline in rough and tumble play while no differences in chase behavior were seen.  
Even though these results were unexpected, they show that both behaviors can be influenced by 
inflammation, but the sex bias may influence how the effects of that inflammation presents itself 
in the more developed brain.  
Our lab is also about to assess the differences in behavior of OVA treated adults. While 
treatment with the mast cell stimulator C48/80 exhibited unexpected results of decreasing social 
avoidance, our lab is in the process of assessing adult social interaction of adults. If the 
behavioral results correlate to the findings observed in C48/80 treatment, mast cells would be 
shown to have an effect on this behavior throughout life. If the behaviors exhibit an opposite 
trend, we could infer that allergy treated animals had a longer recovery time or some 
compensation mechanism developed following treatment.  To separate the two behaviors, future 
studies would look at one on one interaction at the juvenile stage to see if timing of drug delivery 
has an influence on this behavior.  
 While the other areas previously implicated in behavior modulation, such as the BNST, 
habenula, amygdala, and septum, share connections with the hippocampus, the very low number 
of mast cells located in those areas suggest that any influence neuroinflammatory processes play 
in their development or role in neuropsychiatric disorders is not directly regulated by mast cells 
in these regions themselves. However, the projections to them from the hippocampus could 
influence their activation.  Future studies will use immediate early gene analysis using c-Fos to 
see which brain regions show acute activation following mast cell stimulation or allergic 
challenge.   
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 With the allergic challenge, other immune cells present in the brain will also be activated, 
which would add neuroactive compounds into the developing brain from sources other than mast 
cells. While this might seem contradictory to the confound that pharmacological treatment does 
not mimic proper environmental conditions, the precise compounds released by the mast cells in 
the CNS under untreated or inflammatory conditions has not been discovered. Further studies 
will seek to qualitatively and quantitatively examine what contents the mast cells release at 
various time point and manipulate those factors directly.   
Conclusion and future directions 
 Activation in male mast cells through both pharmacological and inflammatory challenges 
suggests that the mast cells may have a greater impact on later life male behavior than the 
females. One recent discovery shows that mast cells have estrogen receptor alpha, which could 
explain the sex difference exhibited by mast cells. That being said, our results showing that 
female behavior changes after gestational inflammation but without mast cells changes leads to 
the conclusion that is highly unlikely any one factor is sufficient to induce the developmental and 
behavioral changes observed in autism. It is more probable that some complex interaction 
between genetics and the environment work together to disrupt the developmental process at 
some point to produce the behavioral phenotype observed in the disease, but our results 
demonstrate that mast cells in the hippocampus are  one possible factor that is disrupted prior to 
ontogeny.   
  Although the exact cause of autism, schizophrenia, and other developmental disorders 
are not fully characterized, dysregulation of the immune system in the developing brain are risk 
factors for the onset of these diseases. Throughout life, myeloid derived immune cells reside in 
the brain and release many neuroactive compounds that also play a role in development (Cote et 
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al., 2007, Galli et al., 2005).  During development, the primary mast cell population resides in 
the same region as many microglia, supporting the idea that microglia and mast cells interact 
during development. Overall, we show that mast cell modulation during early life does disrupt 
the typical behaviors, and many of those behaviors resemble the autistic phenotype. Furthermore, 
inflammation influences the mast cell population and behavior, particularly in males.  
  For inflammatory conditions, future studies will look at the effects of LPS and cromolyn 
combined to find if the main source of the inflammation is due to mast cell activation. If our 
methods can be refined, mast cells seem like a sensible target for research on developmental 
disorders. One such way may even rely on cromolyn sodium, since it is already an FDA 
approved drug though only for treating asthma. If future tests continue to point towards mast cell 
dysregulation as a source of behavioral changes, this drug might serve as a larger therapeutic in 
combating the onset autism in children at risk.   
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